Israeli Drug Makers Battle Over Effexor Generic
This article was originally published in PharmAsia News
Executive Summary
Israeli pharmaceutical companies are battling over an alleged breach of contract that has led to a suit involving a generic version of Pfizer Inc.'s antidepressant Effexor (venlafaxine)